Don't forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic!

Andrea CiorbaVirginia CorazziPiotr Henryk SkarżyńskiMagdalena B SkarżyńskaChiara BianchiniStefano PelucchiStavros Hatzopoulos

Published in: International journal of immunopathology and pharmacology (2020)

Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine, azithromycin, as well as antiviral drugs such as remdesivir, favipiravir and lopinavir can all present potential ototoxic side effects. The data in the literature do not offer specific information on their potential synergetic effects nor on their interactions.

Keyphrases

sars cov
respiratory syndrome coronavirus
systematic review
coronavirus disease
human health
electronic health record
big data
risk assessment
drug induced
climate change
deep learning
smoking cessation